or Try an Advanced Search...

    Virus Like Particle Stocks List

    Symbol Grade Name % Change
    DYAI F Dyadic International, Inc. 0.00
    NVAX F Novavax, Inc. 129.31
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Vaccines Antibodies Biosimilar Biotechnology Clinical Development Coronavirus Fusion Protein Gene Expression Healthcare System Infectious Diseases Influenza Influenza Vaccine Life Sciences Medication Medicine Monoclonal Antibodies Natural Sciences Pharmacy Rabies

    Related ETFs - A few ETFs which own one or more of the above listed Virus Like Particle stocks.

    Symbol Grade Name Weight
    GERM D ETFMG Treatments Testing and Advancements ETF 1.59
    XBI D SPDR S&P Biotech ETF 0.94
    TINY D ProShares Nanotechnology ETF 0.72
    IDNA C iShares Genomics Immunology and Healthcare ETF 0.67
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.62
    View all Virus Like Particle ETFs...
    Compare ETFs
    Compare GERM to XBI Compare TINY to BBC Compare TINY to IDNA

        Virus Like Particle Stocks Recent News

        Date Stock Title
        May 10 NVAX US Stocks Set To End Week Strong With S&P 500 Eyeing Break Above Late-March Peak: Analyst Says He's Still A Buy In May Amid This Positive Signal
        May 10 NVAX Trending tickers: TSMC, Novavax, Anglo American and IAG
        May 10 NVAX Biggest stock movers today: U, NVAX, and more
        May 10 NVAX Novavax Unveils Deal With Sanofi to Co-commercialize COVID-19 Vaccine, Develop Novel Medication
        May 10 NVAX These Stocks Are Moving the Most Today: Novavax, Akamai, Taiwan Semi, SoundHound, JFrog, Dropbox, Yelp, and More
        May 10 NVAX Novavax reports mixed Q1 results; narrows FY24 revenue outlook below estimates
        May 10 NVAX CORRECTED-Novavax erases doubts about its ability to remain in business
        May 10 NVAX UPDATE 3-Novavax signs COVID-19 license deal with Sanofi, revokes 'going concern' warning
        May 10 NVAX Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
        May 10 NVAX Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
        May 9 NVAX Novavax Q1 2024 Earnings Preview
        May 9 NVAX Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street Analysts
        May 7 NVAX Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely
        May 7 NVAX Novavax (NVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 7 NVAX Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024
        May 7 NVAX Novavax top investor calls for removal of three company directors
        May 6 NVAX Novavax stock breaks six-day winning streak
        May 6 NVAX UPDATE 5-Shah Capital urges Novavax shareholders to vote against three directors
        May 6 NVAX Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
        May 6 NVAX UPDATE 2-Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Vaccines Antibodies Biosimilar Biotechnology Clinical Development Coronavirus Fusion Protein Gene Expression Healthcare System Infectious Diseases Influenza Influenza Vaccine Life Sciences Medication Medicine Monoclonal Antibodies Natural Sciences Pharmacy Rabies
        Virus Like Particle

        Browse All Tags